Medline Inc. logo MDLN - Medline Inc.

Price: -- -- | CONSENSUS: Buy DETAILS
STRONG
BUY 0
BUY 10
HOLD 2
SELL 0
STRONG
SELL 0
| PRICE TARGET: $48.91 DETAILS
HIGH: $60.00
LOW: $38.00
MEDIAN: $48.50
CONSENSUS: $48.91
UPSIDE: 32.15%
Annual Quarterly
Metric 2025 2024 2023 2022
Revenue
Revenue 28,432 25,507 23,231 21,448
Cost of Revenue 20,914 19,216 18,008 16,891
Gross Profit 7,518 6,291 5,223 4,557
Operating Expenses
R&D Expenses 0 67 60 58
SG&A Expenses 4,524 4,041 3,807 3,618
Other Expenses 782 (42) (88) 11
Operating Expenses 5,306 4,066 3,779 3,687
Operating Income
Operating Income 2,212 2,225 1,444 870
Interest Expense 0 1,309 1,375 911
Interest Income 0 280 237 27
Profitability
EBITDA 2,916 3,532 2,590 1,854
EBIT 2,212 2,555 1,639 921
Income Before Tax 1,248 1,246 264 10
Income Tax Expense 91 46 30 35
Net Income 1,159 1,200 234 (25)
Per Share Data
EPS (Basic) 1.43 1.52 0.30 -0.03
EPS (Diluted) 1.43 1.52 0.30 -0.03
Shares Outstanding 812.0 787.1 787.1 787.1
Metric 2025 2024 2023
Current Assets
Cash & Cash Equivalents 1,939 250 1,585
Short-Term Investments 0 0 0
Net Receivables 3,533 3,219 2,960
Inventory 4,769 4,456 3,813
Other Current Assets 438 347 451
Total Current Assets 10,679 8,272 8,809
Non-Current Assets
Property, Plant & Equipment 4,778 4,979 4,797
Goodwill 8,079 8,065 7,532
Intangible Assets 13,893 14,559 14,788
Long-Term Investments 0 48 86
Other Non-Current Assets 1,055 55 110
Total Non-Current Assets 27,805 27,706 27,313
Total Assets 38,484 35,978 36,122
Current Liabilities
Account Payables 961 869 696
Short-Term Debt 77 154 122
Deferred Revenue 0 0 0
Other Current Liabilities 0 1,083 972
Total Current Liabilities 2,490 2,440 2,131
Non-Current Liabilities
Long-Term Debt 12,484 16,416 16,442
Deferred Tax Liabilities 0 0 0
Other Non-Current Liabilities 4,224 269 308
Total Non-Current Liabilities 16,708 17,014 17,014
Total Liabilities 19,198 19,454 19,145
Stockholders' Equity
Common Stock 0 16,147 16,556
Retained Earnings (7) 0 0
Accumulated Other Comprehensive Income 27 11 188
Total Stockholders' Equity 10,737 16,524 16,977
Total Liabilities & Equity 38,484 35,978 36,122
Debt Metrics
Total Debt 12,561 16,899 16,828
Net Debt 10,622 16,649 15,243
Metric 2025 2024 2023 2022
Operating Activities
Net Income 1,159 1,200 234 (25)
Depreciation & Amortization 704 977 951 933
Stock-Based Compensation 0 0 0 0
Change in Working Capital 0 (675) 199 (919)
Other Non-Cash Items (119) 291 325 212
Operating Cash Flow 1,744 1,769 1,685 187
Investing Activities
Capital Expenditure 0 (364) (285) (254)
Acquisitions 0 (1,126) (16) (17)
Purchases of Investments 0 0 (16) 0
Sales/Maturities of Investments 0 0 5 7
Other Investing Activities (474) (3) 0 0
Investing Cash Flow (474) (1,493) (312) (264)
Financing Activities
Net Debt Issuance (4,092) (75) (77) (61)
Stock Repurchased 0 (20) 0 0
Dividends Paid 0 0 0 0
Other Financing Activities 4,491 (1,518) (114) (23)
Financing Cash Flow 399 (1,613) (191) (84)
Cash Position
Net Change in Cash 1,689 (1,335) 1,585 0
Cash at Beginning 250 1,585 0 0
Cash at End 1,939 250 1,585 0
Free Cash Flow 1,744 1,405 1,400 (67)
Key Metrics 2025 2024 2023 2022
Income Statement
Revenue 28,432 25,507 23,231 21,448
Gross Profit 7,518 6,291 5,223 4,557
Operating Income 2,212 2,225 1,444 870
Net Income 1,159 1,200 234 (25)
EPS (Diluted) 1.43 1.52 0.30 -0.03
Balance Sheet
Cash & Equivalents 1,939 250 1,585
Total Assets 38,484 35,978 36,122
Total Debt 12,561 16,899 16,828
Stockholders' Equity 10,737 16,524 16,977
Cash Flow
Operating Cash Flow 1,744 1,769 1,685 187
Capital Expenditure 0 (364) (285) (254)
Free Cash Flow 1,744 1,405 1,400 (67)